Abstract
AbstractThe integration of machine learning (ML) and artificial intelligence (AI) techniques in life-course epidemiology offers remarkable opportunities to advance our understanding of the complex interplay between biological, social, and environmental factors that shape health trajectories across the lifespan. This perspective summarizes the current applications, discusses future potential and challenges, and provides recommendations for harnessing ML and AI technologies to develop innovative public health solutions. ML and AI have been increasingly applied in epidemiological studies, demonstrating their ability to handle large, complex datasets, identify intricate patterns and associations, integrate multiple and multimodal data types, improve predictive accuracy, and enhance causal inference methods. In life-course epidemiology, these techniques can help identify sensitive periods and critical windows for intervention, model complex interactions between risk factors, predict individual and population-level disease risk trajectories, and strengthen causal inference in observational studies. By leveraging the five principles of life-course research proposed by Elder and Shanahan—lifespan development, agency, time and place, timing, and linked lives—we discuss a framework for applying ML and AI to uncover novel insights and inform targeted interventions. However, the successful integration of these technologies faces challenges related to data quality, model interpretability, bias, privacy, and equity. To fully realize the potential of ML and AI in life-course epidemiology, fostering interdisciplinary collaborations, developing standardized guidelines, advocating for their integration in public health decision-making, prioritizing fairness, and investing in training and capacity building are essential. By responsibly harnessing the power of ML and AI, we can take significant steps towards creating healthier and more equitable futures across the life course.
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Wagner C, Carmeli C, Jackisch J, Kivimaki M, van der Linden BWA, Cullati S, Chiolero A. Life course epidemiology and public health. Lancet Public Health. 2024;9(4):e261–9.
2. Elder Jr GH, Shanahan MJ. The Life Course and Human Development. In: Damon W, Lerner RM, editors. Handbook of Child Psychology. Volume 1, edn. New Jersey: Wiley; 2007.
3. Bi Q, Goodman KE, Kaminsky J, Lessler J. What is machine learning? A primer for the epidemiologist. Am J Epidemiol. 2019;188(12):2222–39.
4. Sharma D, Gotlieb N, Farkouh ME, Patel K, Xu W, Bhat M. Machine learning approach to classify cardiovascular disease in patients with nonalcoholic fatty liver disease in the UK Biobank Cohort. J Am Heart Assoc. 2022;11(1):e022576.
5. Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS ONE. 2017;12(4):e0174944.